Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novan Inc | 0 | 24 | 0 | 3 | €0.001 | - | - |
| Moleculin Biotech Inc | 3 | 27 | 2 | 2 | €0.41 | €18.42 | 4393.659% |
| Evoke Pharma Inc. | 0 | 22 | 0 | 1 | €0.43 | - | - |
| InVivo Therapeutics Holdings | 1 | 18 | 0 | 1 | €0.32 | €1.60 | 403.145% |
| Bellicum Pharmaceuticals Inc. | 0 | 14 | 0 | 1 | €0.064 | - | - |
| Neptune Wellness Solutions Inc | 0 | 14 | 0 | 1 | €0.14 | - | - |
| T2 Biosystems Inc. | 0 | 13 | 0 | 0 | €0.16 | - | - |
| Trevena Inc. | 1 | 13 | 1 | 3 | €0.32 | €8.37 | 2535.087% |
| BioLase Inc. | 0 | 7 | 0 | 1 | €0.067 | - | - |
| Organovo Holdings Inc. | 0 | 5 | 0 | 1 | €0.95 | €3.00 | 216.122% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 1 | €2.38 | €7.00 | 194.118% |
| Nymox Pharmaceutical Corp. | 0 | 3 | 0 | 0 | €0.23 | - | - |
| Waters Corp. | 0 | 3 | 0 | 0 | €292.80 | €253.83 | -13.311% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €2.85 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 2 | €0.94 | €6.49 | 592.895% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €6.15 | €7.00 | 13.821% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 1 | €3.46 | - | - |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 1 | €0.60 | - | - |
| Fibrogen Inc. | 2 | 4 | 1 | 1 | €1.00 | €0.000 | -100.000% |
| Daiichi Sankyo Co Ltd | 0 | 1 | 0 | 0 | €28.60 | - | - |
| Agenus Inc. | 2 | 3 | 0 | 0 | €0.41 | €7.30 | 1664.911% |
| Grifols S.A. ADR | 0 | 1 | 0 | 0 | €5.75 | - | - |
| Sangamo Therapeutics Inc. | 11 | 12 | 0 | 1 | €0.50 | €2.79 | 460.461% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 1 | €0.67 | €3.00 | 346.694% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €3.10 | - | - |